Molecular characterization of an EWSR1–POU5F1 fusion associated with a t(6;22) in an undifferentiated soft tissue sarcoma
- 31 August 2011
- journal article
- case report
- Published by Elsevier BV in Cancer Genetics
- Vol. 204 (8), 423-429
- https://doi.org/10.1016/j.cancergen.2011.05.006
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glandsThe Journal of Pathology, 2008
- Myoepithelial Carcinoma of Soft Tissue in Children: An Aggressive Neoplasm Analyzed in a Series of 29 CasesThe American Journal of Surgical Pathology, 2007
- OCT‐4, an embryonic stem cell marker, is highly expressed in bladder cancerInternational Journal of Cancer, 2007
- Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial TissuesCell, 2005
- EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12)Genes, Chromosomes and Cancer, 2005
- Myoepithelial Tumors of Soft TissueThe American Journal of Surgical Pathology, 2003
- Chromosomal translocations and sarcomasCurrent Opinion in Oncology, 2002
- Biology of EWS/ETS fusions in Ewing's family tumorsOncogene, 2001
- Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cellsNature Genetics, 2000
- Molecular Biology of the Ewing’s Sarcoma/Primitive Neuroectodermal Tumor FamilyJournal of Clinical Oncology, 2000